Incisive coverage of the issues important to vaping. Plus critical debate over the issues and impacts of regulation in both Canada and the U.S.
Episodes
7 days ago
7 days ago
British American Tobacco is one of the oldest and largest of the world's tobacco companies. But they are also among the most innovative. Through its U.S. subsidiary, R.J. Reynolds, BAT was the first to receive marketing authorization from the FDA through the PMTA process for the Vuse Solo e-cigarette and tobacco-flavored e-liquid pods. This marked a significant milestone for the industry.
Joining us today to discuss the challenges of the FDA’s PMTA process, the importance of science, and the contentious battle over THR is Elaine Round, the Group Head of Life Sciences at BAT. Hear about BAT’s commitment to tobacco harm reduction and concerns over misperceptions of harm.
Only on RegWatch by RegulatorWatch.com.
Released: September 29, 2024
Produced by Brent Stafford
This episode is supported by DEMAND VAPE
Make RegWatch happen, go to https://support.regulatorwatch.com
#RegWatch #VapeNews
Saturday Sep 21, 2024
Saturday Sep 21, 2024
The U.S. vaping industry faces a pivotal moment as the Supreme Court prepares to review a Fifth Circuit Court of Appeals decision. This ruling overturned FDA Marketing Denial Orders, including those affecting Triton Vapes LLC, seeking authorization to sell flavored nicotine vaping products.
A favorable ruling could not only overturn these denials but also potentially unravel the FDA’s authority over vape sales entirely.
Today, attorney and long-time vaping advocate Greg Troutman joins us to analyze this critical SCOTUS hearing. Could this be the end of the vaping industry’s relentless regulatory battle?
Discover the answers, only on RegWatch by RegulatorWatch.com.
Released: September 21, 2024
Produced by Brent Stafford
This episode is supported by DEMAND VAPE
Make RegWatch happen, go to https://support.regulatorwatch.com
#RegWatch #VapeNews
Tuesday Aug 27, 2024
Tuesday Aug 27, 2024
This groundbreaking network television investigation was the first to expose how tobacco companies were deliberately increasing nicotine levels to make cigarettes more addictive. The revelations aired on ABC’s ‘DayOne’ news magazine on February 28, 1994, followed by a second episode on March 7, 1994.
Now, digitally remastered and presented here for the first time together in an exclusive showing supported by Demand Vape, RegWatch brings you both parts of this pivotal investigation. Viewers will recognize several key figures who join us as guests on our show.
Don’t miss the chance to revisit the evidence that forced Big Tobacco to its knees and inadvertently ignited the war on nicotine.
Released: August 27, 2024
Produced by Brent Stafford
This episode is supported by DEMAND VAPE
Make RegWatch happen, go to https://support.regulatorwatch.com
Monday Aug 19, 2024
Monday Aug 19, 2024
Industry funding taints all science, research, and tobacco harm reduction advocacy, no matter how stringent the firewalls or how far the funding is removed. This criticism is a convenient argument for detractors of safer nicotine products to deny the truth about nicotine and relative risk.
Joining us today to unpack the dangers and consequences of dismissing the truth about tobacco harm reduction is Clifford E. Douglas, President and CEO of Global Action to End Smoking.
Has public understanding about safer nicotine products been shortchanged?
Find out! Only on RegWatch by RegulatorWatch.com.
Released: August 19, 2024
Produced by Brent Stafford
Make RegWatch happen, go to https://support.regulatorwatch.com
#RegWatch #VapeNews
Tuesday Aug 13, 2024
Tuesday Aug 13, 2024
Join Brent Stafford of RegWatch as he hosts an engaging panel with renowned harm reduction advocates from Australia, the UK, and Canada. In this lively discussion, our experts tackle critical issues facing Commonwealth countries.
Featuring Fiona Patten, Martin Cullip, and Maria Papaioannoy, this conversation dives deep into the contradictions and complexities of harm reduction strategies in the Commonwealth. Don't miss their insightful perspectives and thought-provoking debate on the future of tobacco control and vaping regulations.
Live Broadcast: June 13, 2024
Released on RegWatch: August 13, 2024
Hosted By: Brent Stafford
Produced By the Global Forum on Nicotine
Watch more RegWatch on GFN at GFN.TV
Make RegWatch happen, go to https://support.regulatorwatch.com
#RegWatch #VapeNews
Thursday Aug 01, 2024
Thursday Aug 01, 2024
It would be a terrible irony if not for the fact that it appears deliberate. FDA’s regulation of the U.S. vaping industry not only delivers big tobacco a de facto monopoly on the legal sale of vaping products, but it also grants them a monopoly on harm reduction. Yet it decries “tobacco harm reduction” as an “industry term.”
Joining us today to dissect this disturbing paradox is eminent scientist and cardiologist Dr. Konstantinos Farsalinos. This interview was shot on location in Warsaw, Poland, at the Global Forum on Nicotine.
Is tobacco control irresponsible?
Find out!
Only on RegWatch by RegulatorWatch.com.
Released: August 1, 2024
Produced by Brent Stafford
This episode is supported by DEMAND VAPE
Make RegWatch happen, go to https://support.regulatorwatch.com
#RegWatch #VapeNews
Thursday Jul 18, 2024
Thursday Jul 18, 2024
Over the past decade, how many people have been chided, misled, bullied, or driven away from considering reduced-risk nicotine products as a safer alternative to combustible tobacco? It’s a difficult question with a stark answer.
Joining us for part two of our special two-part edition of RegWatch is former NJOY exec Jeffrey Weiss. Weiss's tenure at NJOY was significant and consequential, serving on the board, as general counsel, and during the tumultuous years as interim president. His time at NJOY concluded with the Altria purchase in 2023.
Are tobacco control policies putting lives at stake?
Find out!
Only on RegWatch by RegulatorWatch.com.
Released: July 18, 2024
Produced by Brent Stafford
This episode is supported by DEMAND VAPE
Make RegWatch happen, go to https://support.regulatorwatch.com
#RegWatch #VapeNews
Thursday Jun 27, 2024
Thursday Jun 27, 2024
NJOY will be the first company to have flavored e-cigarette products legally sold on the U.S. market. The decision came late last week when the U.S. FDA announced it had issued marketing granted orders to NJOY LLC for four menthol-flavored e-cigarette products under the PMTA pathway.
It’s the first time the FDA has authorized a non-tobacco flavored e-cigarette product.
Joining us today for a special two-part edition of RegWatch is former NJOY exec Jeffrey Weiss, whose tenure at NJOY was significant and consequential. Weiss served on the board, as general counsel, and during the tumultuous years as interim president. His time at NJOY ended with the completion of the Altria purchase in 2023.
What prompted the FDA to break with its de facto ban on flavors? What was tobacco-control’s reaction to the news? And could more flavored products be authorized soon?
Find out, and more!
Only on RegWatch by RegulatorWatch.com.
Released: June 27, 2024
Produced by Brent Stafford
This episode is supported by DEMAND VAPE
Make RegWatch happen, go to https://support.regulatorwatch.com
#RegWatch #VapeNews
Saturday Jun 22, 2024
Saturday Jun 22, 2024
Despite enduring years of attacks by tobacco control, misinformation, and an onslaught of regulations leading to product restrictions and bans, the U.S. vaping industry continues its remarkable growth.
In 2024, U.S. vaping is expected to exceed $12 billion in sales—not including the black market—making it a goliath in both size and scope.
Joining us today in this episode of RegWatch is Barnaby Page, editorial director at Tamarind Intelligence, a global market research and regulatory analysis firm specialized in the vaping, cannabis, and tobacco sectors via three brands: ECigIntelligence, CannIntelligence, and TobaccoIntelligence.
How many adult vapers are there in the U.S.? What’s the impact of the PMTA process on vape stores?
Find out, and more!
Only on RegWatch by RegulatorWatch.com.
Released: June 22, 2024
Produced by Brent Stafford
This episode is supported by DEMAND VAPE
Make RegWatch happen, go to https://support.regulatorwatch.com
#RegWatch #VapeNews
Tuesday Jun 04, 2024
Tuesday Jun 04, 2024
Often, much of the research on e-cigarettes, nicotine, and youth use appears flawed or even outrageous. According to mainstream media, vaping could be responsible for everything from shrinking testicles and plummeting sperm counts to tooth decay and gum disease.
However, some research could be downright dangerous, making claims that nicotine vapes cause cancer, heart disease, and stroke, and that they are riskier than combustible tobacco.
Joining us today to discuss the ongoing issue of questionable science on safer nicotine products is Dr. Arielle Selya, a behavioral scientist at PinneyAssociates, a U.S.-based firm that provides consulting services on tobacco harm reduction to Juul Labs.
Only on RegWatch by RegulatorWatch.com.
Released: June 4, 2024
Produced by Brent Stafford
This episode is supported by DEMAND VAPE
Make RegWatch happen, go to https://support.regulatorwatch.com
#RegWatch #VapeNews